千红制药
(002550)
| 流通市值：59.99亿 | | | 总市值：80.50亿 |
| 流通股本：9.54亿 | | | 总股本：12.80亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 354,959,055.62 | 677,499,819.5 | 491,049,981.31 | 439,284,660.86 |
| 交易性金融资产 | 787,455,152.53 | 604,361,957.22 | 594,016,456.17 | 610,443,495.49 |
| 应收票据及应收账款 | 241,015,968.79 | 220,914,556.23 | 259,134,608.23 | 251,784,324.02 |
| 其中：应收票据 | 2,807,516.8 | 5,090,461.29 | 1,803,610.64 | 2,564,002.6 |
| 应收账款 | 238,208,451.99 | 215,824,094.94 | 257,330,997.59 | 249,220,321.42 |
| 应收款项融资 | 24,825,469.36 | 23,233,424.57 | 39,962,656.64 | 28,613,574.02 |
| 预付款项 | 24,898,163.55 | 26,203,009.68 | 16,629,313.08 | 39,998,798.01 |
| 其他应收款合计 | 18,393,768.36 | 18,694,578.34 | 18,940,289 | 22,123,413.46 |
| 存货 | 405,194,221.29 | 403,969,001.22 | 372,442,700.01 | 382,973,790.82 |
| 合同资产 | - | - | 0 | - |
| 一年内到期的非流动资产 | 84,610,894.21 | 10,916,410.96 | 76,202,295.66 | 151,922,679.21 |
| 其他流动资产 | 57,467,574.02 | 42,928,048.66 | 41,349,429.1 | 10,310,773.32 |
| 流动资产合计 | 1,998,820,267.73 | 2,028,720,806.38 | 1,909,727,729.2 | 1,937,455,509.21 |
| 非流动资产: | | | | |
| 债权投资 | 46,456,227.99 | 130,316,060.55 | 129,573,252.3 | 93,307,318.88 |
| 长期股权投资 | 4,419,495.13 | 2,652,695.26 | 4,582,046.61 | 3,534,037.88 |
| 固定资产 | 540,471,556.66 | 555,211,612.16 | 568,682,078.84 | 469,330,851.13 |
| 在建工程 | 150,320,554.97 | 136,345,283.69 | 110,385,196.96 | 78,029,809.82 |
| 使用权资产 | 2,477,461.57 | 2,668,035.54 | 2,858,609.51 | - |
| 无形资产 | 105,565,384.13 | 106,387,963.95 | 107,214,857.92 | 108,001,425.07 |
| 开发支出 | 175,643,576.57 | 165,264,369.47 | 154,202,438.47 | 143,226,216.58 |
| 商誉 | 11,135,053.57 | 11,135,053.57 | 11,135,053.57 | 11,135,053.57 |
| 长期待摊费用 | 16,745,507.85 | 17,828,282.91 | 18,824,650.23 | 18,963,515.39 |
| 递延所得税资产 | 69,817,484.5 | 66,348,730.06 | 66,520,796.11 | 57,988,002.13 |
| 其他非流动资产 | 6,474,693.78 | 8,987,356.78 | 4,466,266.77 | 94,516,746.05 |
| 非流动资产合计 | 1,129,526,996.72 | 1,203,145,443.94 | 1,178,445,247.29 | 1,078,032,976.5 |
| 资产总计 | 3,128,347,264.45 | 3,231,866,250.32 | 3,088,172,976.49 | 3,015,488,485.71 |
| 流动负债: | | | | |
| 短期借款 | 29,999,799.5 | - | - | - |
| 应付票据及应付账款 | 84,347,180.88 | 94,550,214.23 | 78,819,565.67 | 59,290,297.07 |
| 应付账款 | 84,347,180.88 | 94,550,214.23 | 78,819,565.67 | 59,290,297.07 |
| 合同负债 | 3,299,202.5 | 6,214,808.52 | 7,636,333.82 | 5,332,641.55 |
| 应付职工薪酬 | 14,050,787.45 | 16,587,992.06 | 38,651,552.9 | 27,234,980.46 |
| 应交税费 | 24,212,094.34 | 20,113,100.76 | 7,801,982.31 | 12,511,235.02 |
| 其他应付款合计 | 67,002,416.03 | 66,566,328.7 | 20,563,433.5 | 13,368,446.54 |
| 其他流动负债 | 76,388,212.58 | 74,028,850.91 | 72,047,339.43 | 45,970,346.59 |
| 流动负债合计 | 299,299,693.28 | 278,061,295.18 | 225,520,207.63 | 163,707,947.23 |
| 非流动负债: | | | | |
| 租赁负债 | 3,118,305.95 | 3,095,092.75 | 3,072,052.36 | - |
| 递延收益 | 94,610,694.37 | 93,942,837.54 | 88,584,980.71 | 88,439,980.88 |
| 递延所得税负债 | 4,692,310.78 | 4,716,809.98 | 4,776,859.1 | 3,714,527.32 |
| 非流动负债合计 | 102,421,311.1 | 101,754,740.27 | 96,433,892.17 | 92,154,508.2 |
| 负债合计 | 401,721,004.38 | 379,816,035.45 | 321,954,099.8 | 255,862,455.43 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,279,800,000 | 1,279,800,000 | 1,279,800,000 | 1,279,800,000 |
| 资本公积 | 34,373,982.06 | 30,211,482.06 | 41,422,004.56 | 41,422,004.56 |
| 减:库存股 | 156,878,283.75 | 156,878,283.75 | 170,863,806.25 | 170,863,806.25 |
| 其他综合收益 | -691,938.49 | -1,990,491.07 | -549,240.38 | -2,020,767.45 |
| 盈余公积 | 370,372,037.78 | 370,372,037.78 | 370,372,037.78 | 327,210,615.91 |
| 未分配利润 | 1,211,274,313.52 | 1,332,773,697.64 | 1,247,718,636.45 | 1,275,310,803.61 |
| 归属于母公司股东权益合计 | 2,738,250,111.12 | 2,854,288,442.66 | 2,767,899,632.16 | 2,750,858,850.38 |
| 少数股东权益 | -11,623,851.05 | -2,238,227.79 | -1,680,755.47 | 8,767,179.9 |
| 股东权益合计 | 2,726,626,260.07 | 2,852,050,214.87 | 2,766,218,876.69 | 2,759,626,030.28 |
| 负债和股东权益合计 | 3,128,347,264.45 | 3,231,866,250.32 | 3,088,172,976.49 | 3,015,488,485.71 |
| 公告日期 | 2026-08-08 | 2026-04-24 | 2026-04-24 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |